Rx Processing Corp. Announces Order Processing Underway

Rx Processing Corporation (OTC:RXPC) continues its phased implementation in its return to fully operational status with the introduction of an enhanced online ordering system. This continuing action fosters an environment that enables access to lifesaving prescription medications and laboratory diagnostic products for advocates / pharmacies and the related community of health care providers.

Rx Processing Corp. has positioned itself to achieve a common goal since its introduction to the market in 2003. Critical to this process, we have taken innumerable actions to further secure our operational environment. The basis of the environment, defined by strength of leadership, relationships established with business partners, and a dedication to the needs of our advocates. We mutually identify, express and address the overall concerns of healthcare providers and our community. The proprietary operating environment will continue in its mission to increase the advocate base and in turn meet or potentially exceed revenue projections for fiscal year 2007.

“This established ordering architecture, effectively competes and positions the company to provide service to citizens in need of affordable health care solutions,” stated CEO Peter Fiorillo. “Our dream, the well-being of our family, children, friends and community is exemplified in our resumption of online ordering.”

O/S: 61,633,577 Float: 23,244,502 Shareholders: 450

Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients’ health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.

Safe Harbor Statement:

All statements other than statements of historical fact included in this press release are “forward-looking statements.” The forward-looking statements, including those about the company’s future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company’s control, and may yield results differing materially from those anticipated.